[Different indications of photodynamic therapy in ophthalmology].
BACKGROUND
Photodynamic therapy (PDT) in eye disease was approved 10 years ago for age-related macular degeneration (AMD). Thereafter it was approved for choroidal neovascularisation (CNV) in pathological myopia. The treatment regimen is based on two prospective, multicentre trials (TAP and VIP studies).


METHODS
In the meantime PDT has been successfully used also in several other ocular diseases. PDT is minimally invasive and has an excellent side effect profile. Different diseases and their treatment with PDT are discussed.


RESULTS
The treatments of idiopathic CNV, secondary CNV in inflammatory diseases of the retina and choroid, choroidal haemangioma, vasoproliferative tumours, malignant melanoma of the choroid, and central serous chorioretinopathy with PDT are described. In most patients the disease progression can be stopped and in some the PDT treatment results in visual improvement. The prognosis is better in patients with early disease detection and small lesions.


CONCLUSIONS
Several retinal and choroidal diseases can be treated successfully with PDT. Except for AMD and pathological myopia, PDT is an off label treatment.
Lang
G E
GE
Augenklinik, Universitätsklinikum Ulm. gabriele.lang@uniklinik-ulm.de
Mennel
S
S
Spital
G
G
Wachtlin
J
J
Jurklies
B
B
Heimann
H
H
Damato
B
B
Meyer
C H
CH
D015862:Choroid Diseases / Q000188:drug therapy*; D005858:Germany; D006801:Humans; D009883:Ophthalmic Solutions / Q000627:therapeutic use*; D009885:Ophthalmology / Q000379:methods / Q000639:trends*; D010778:Photochemotherapy / Q000379:methods / Q000639:trends*; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D012164:Retinal Diseases / Q000188:drug therapy*
D009883:Ophthalmic Solutions; D017319:Photosensitizing Agents